Discovery of T-Cell Infection and Apoptosis by Middle East Respiratory Syndrome Coronavirus

Journal of Infectious Diseases

Volumn 213, Issue 6, 2016, Pages 877-879

  Ying, Tianlei ^a   Li, Wei ^b   Dimitrov, Dimiter S ^b  

^a FUDAN UNIVERSITY   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

apoptosis; cytokine chemokine; DPP4; IFN; immunopathology; MERS CoV; T cell

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; M PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADAPTIVE IMMUNITY; APOPTOSIS; BLOOD CLOTTING DISORDER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CORONAVIRUS INFECTION; CYTOKINE RELEASE; DISEASE COURSE; EDITORIAL; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LEUKOCYTE COUNT; LYMPHOCYTOPENIA; LYMPHOID CELL; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS INFECTION; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; SURVIVAL RATE; T LYMPHOCYTE; THROMBOCYTOPENIA; VIRUS REPLICATION; ANIMAL; PHYSIOLOGY; VIROLOGY;

ANIMALS; APOPTOSIS; HUMANS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; T-LYMPHOCYTES;

EID: 84964879131     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv381     Document Type: Editorial

References (18)

1. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV)-Republic of Korea. 26 June 2015. http://www.who.int/csr/don/26-june-2015-mers-korea/en/. Accessed 16 July 2015.
2. Gralinski LE, Baric RS. Molecular pathology of emerging coronavirus infections. J Pathol 2015; 235:185-95.
3. van den Brand JM, Smits SL, Haagmans BL. Pathogenesis of Middle East respiratory syndrome coronavirus. J Pathol 2015; 235:175-84.
4. Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 2014; 160:389-97.
5. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013; 13:752-61.
6. Siu KL, Yeung ML, Kok KH, et al. Middle east respiratory syndrome coronavirus 4a protein is a doublestranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response. J Virol 2014; 88:4866-76.
7. Yang Y, Zhang L, Geng H, et al. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell 2013; 4:951-61.
8. Niemeyer D, Zillinger T, Muth D, et al. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J Virol 2013; 87:12489-95.
9. Zielecki F, Weber M, Eickmann M, et al. Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J Virol 2013; 87:5300-4.
10. Faure E, Poissy J, Goffard A, et al. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside? PLoS One 2014; 9:e88716.
11. Zhou J, Chu H, Li C, et al. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis 2014; 209:1331-42.
12. Chu H, Zhou J, Wong BH, et al. Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response. Virology 2014; 454-455:197-205.
13. Zhao J, Li K, Wohlford-Lenane C, et al. Rapid generation of amousemodel for Middle East respiratory syndrome. Proc Natl Acad Sci U S A 2014; 111:4970-5.
14. Prescott JDWE, Falzarano D, Scott DP, Feldmann H, Munster VJ. Defining the effects of immunosuppression in the rhesus model of Middle East respiratory syndrome (MERS). Presented at: 33rd Annual Meeting of the American Society for Virology, Fort Collins, Colorado, 21-25 June 2014.
15. Josset L, Menachery VD, Gralinski LE, et al. Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. mBio 2013; 4:e00165-00113.
16. Ishii T, Ohnuma K, Murakami A, et al. CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. Proc Natl Acad Sci U S A 2001; 98:12138-43.
17. Shirato K, Kawase M, Matsuyama S. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J Virol 2013; 87:12552-61.
18. Scheuplein VA, Seifried J, Malczyk AH, et al. High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus. J Virol 2015; 89:3859-69.